Alglucosidase Alfa
Glycogen Storage Disease
Genzyme, a Sanofi Companyprotein_peptideDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Glycogen Storage Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
HEPTANOIN, TRI- | D |
Same molecule, other indications
Alglucosidase Alfa is also rated in:
glycogen storage disease due to acid maltase deficiency, late-onsetDormant
BBB
Indicative ·
78 / 100
View asset →glycogen storage disease due to acid maltase deficiency, infantile onsetDormant
BB
Indicative ·
69 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →